About MedImmune
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has three marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life-threatening diseases.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of MedImmune
Similar companies
News about MedImmune
Here you will find MedImmune Limited
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Causus_lichtensteinii
Fear_of_the_dark
West_syndrome
A Better Target for B-Cell Lymphomas - From a Library of MAG Antagonists to Nanomolar CD22 Ligands
Researchers identify genes linked to chemoresistance
Medis - Hafnarfjörður, Iceland
Bloodroot
Causus_maculatus
Crucell Doubles Production of Quinvaxem in 2008 and Prepares Move to New Korean Production Site to Facilitate Growth
Health_insurance
In a role reversal, RNAs proofread themselves - Molecular photographs of an enzyme bound to RNA reveal a new, inherent quality control mechanism
